Nucleophosmin and its complex network: a possible therapeutic target in hematological diseases
- 31 January 2011
- journal article
- review article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 30 (23), 2595-2609
- https://doi.org/10.1038/onc.2010.646
Abstract
Nucleophosmin (NPM, also known as B23, numatrin or NO38) is a ubiquitously expressed phosphoprotein belonging to the nucleoplasmin family of chaperones. NPM is mainly localized in the nucleolus where it exerts many of its functions, but a proportion of the protein continuously shuttles between the nucleus and the cytoplasm. A growing number of cellular proteins have been described as physical interactors of NPM, and consequently, NPM is thought to have a relevant role in diverse cellular functions, including ribosome biogenesis, centrosome duplication, DNA repair and response to stress. NPM has been implicated in the pathogenesis of several human malignancies and intriguingly, it has been described both as an activating oncogene and a tumor suppressor, depending on cell type and protein levels. In fact, increased NPM expression is associated with different types of solid tumors whereas an impairment of NPM function is characteristic of a subgroup of hematolologic malignancies. A large body of experimental evidence links the deregulation of specific NPM functions to cellular transformation, yet the molecular mechanisms through which NPM contributes to tumorigenesis remain elusive. In this review, we have summarized current knowledge concerning NPM functions, and attempted to interpret its multifaceted and sometimes apparently contradictory activities in the context of both normal cellular homeostasis and neoplastic transformation.Keywords
This publication has 170 references indexed in Scilit:
- Protein B23/Nucleophosmin/Numatrin Nuclear Dynamics in Relation to Protein Kinase CK2 and Apoptotic Activity in Prostate CellsBiochemistry, 2010
- Centromere-Specific Assembly of CENP-A Nucleosomes Is Mediated by HJURPCell, 2009
- Transcriptional control by PARP-1: chromatin modulation, enhancer-binding, coregulation, and insulationCurrent Opinion in Cell Biology, 2008
- The nucleolar SUMO‐specific protease SENP3 reverses SUMO modification of nucleophosmin and is required for rRNA processingEMBO Reports, 2008
- Nucleophosmin acts as a novel AP2α‐binding transcriptional corepressor during cell differentiationEMBO Reports, 2007
- Restoration of p53 function leads to tumour regression in vivoNature, 2007
- Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replicationNature, 2006
- Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpointsNature, 2006
- The human CENP-A centromeric nucleosome-associated complexNature, 2006
- Nucleophosmin is selectively deposited on mRNA during polyadenylationNature Structural & Molecular Biology, 2006